Sue Zhou

434 total citations
9 papers, 345 citations indexed

About

Sue Zhou is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Sue Zhou has authored 9 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 4 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Sue Zhou's work include Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (3 papers) and Estrogen and related hormone effects (2 papers). Sue Zhou is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (3 papers) and Estrogen and related hormone effects (2 papers). Sue Zhou collaborates with scholars based in United States and United Kingdom. Sue Zhou's co-authors include Ping Kang, Deepak Dalvie, Cathie Xiang, Michael Zientek, R. Scott Obach, Alan Deese, Evan Smith, Gregory S. Walker, Kieran F. Geoghegan and Theunis C. Goosen and has published in prestigious journals such as European Journal of Pharmacology, Chemical Research in Toxicology and Drug Metabolism and Disposition.

In The Last Decade

Sue Zhou

9 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sue Zhou United States 9 197 117 98 41 34 9 345
Aaron M. Moss United States 7 117 0.6× 114 1.0× 193 2.0× 47 1.1× 34 1.0× 10 453
Suzanne Tay United States 10 144 0.7× 166 1.4× 112 1.1× 40 1.0× 16 0.5× 15 408
I. Gardner United Kingdom 10 195 1.0× 133 1.1× 103 1.1× 43 1.0× 67 2.0× 17 510
Soraya Madani United States 6 291 1.5× 86 0.7× 153 1.6× 43 1.0× 57 1.7× 8 534
Sylvie Klieber France 13 193 1.0× 117 1.0× 105 1.1× 38 0.9× 21 0.6× 18 436
Ryan Takahashi United States 13 189 1.0× 173 1.5× 129 1.3× 47 1.1× 31 0.9× 31 443
Noriko Masubuchi Japan 13 142 0.7× 161 1.4× 168 1.7× 35 0.9× 23 0.7× 17 450
B. Kevin Park United Kingdom 10 160 0.8× 95 0.8× 91 0.9× 51 1.2× 111 3.3× 15 416
Lewis J. Klunk United States 13 120 0.6× 159 1.4× 91 0.9× 28 0.7× 22 0.6× 25 454
B. Kevin Park United Kingdom 13 157 0.8× 151 1.3× 93 0.9× 27 0.7× 61 1.8× 15 485

Countries citing papers authored by Sue Zhou

Since Specialization
Citations

This map shows the geographic impact of Sue Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Zhou more than expected).

Fields of papers citing papers by Sue Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Zhou. The network helps show where Sue Zhou may publish in the future.

Co-authorship network of co-authors of Sue Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Sue Zhou. A scholar is included among the top collaborators of Sue Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Zhou. Sue Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Walsky, Robert L., R. Scott Obach, Ruth Hyland, et al.. (2012). Selective Mechanism-Based Inactivation of CYP3A4 by CYP3cide (PF-04981517) and Its Utility as an In Vitro Tool for Delineating the Relative Roles of CYP3A4 versus CYP3A5 in the Metabolism of Drugs. Drug Metabolism and Disposition. 40(9). 1686–1697. 74 indexed citations
2.
Dalvie, Deepak, Cathie Xiang, Ping Kang, & Sue Zhou. (2012). Interspecies variation in the metabolism of zoniporide by aldehyde oxidase. Xenobiotica. 43(5). 399–408. 41 indexed citations
3.
Xiang, Cathie, Minerva Batugo, David C. Gale, et al.. (2009). Characterization of Human Corneal Epithelial Cell Model As a Surrogate for Corneal Permeability Assessment: Metabolism and Transport. Drug Metabolism and Disposition. 37(5). 992–998. 55 indexed citations
4.
Grant, Stephan K., Qin Zhang, Aihua Zou, et al.. (2009). Discovery of a novel class of targeted kinase inhibitors that blocks protein kinase C signaling and ameliorates retinal vascular leakage in a diabetic rat model. European Journal of Pharmacology. 627(1-3). 16–25. 10 indexed citations
6.
Kang, Ping, Deepak Dalvie, Evan Smith, et al.. (2008). Bioactivation of Flutamide Metabolites by Human Liver Microsomes. Drug Metabolism and Disposition. 36(7). 1425–1437. 41 indexed citations
7.
Dalvie, Deepak, Ping Kang, Michael Zientek, et al.. (2008). Effect of Intestinal Glucuronidation in Limiting Hepatic Exposure and Bioactivation of Raloxifene in Humans and Rats. Chemical Research in Toxicology. 21(12). 2260–2271. 48 indexed citations
8.
Kang, Ping, Deepak Dalvie, Evan Smith, Sue Zhou, & Alan Deese. (2007). Identification of a Novel Glutathione Conjugate of Flutamide in Incubations with Human Liver Microsomes. Drug Metabolism and Disposition. 35(7). 1081–1088. 34 indexed citations
9.
Kalgutkar, Amit S., Sue Zhou, Odette A. Fahmi, & Tim Taylor. (2003). Influence of Lipophilicity on the Interactions of N-Alkyl-4-phenyl-1,2,3,6-tetrahydropyridines and Their Positively Charged N-Alkyl-4-phenylpyridinium Metabolites with Cytochrome P450 2D6. Drug Metabolism and Disposition. 31(5). 596–605. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026